News flow

Regulatory Press Releases

14 June 2021

Congrats to our partner Gesynta Pharma which has today announced progresses across the #development program for it… https://t.co/VWMsbjDUwO

10 June 2021

We’re delighted to be welcoming Mattias Springfelter back to Orexo in his new role as Head of Pharmaceutical Develo… https://t.co/ZrO455wJRz

7 June 2021

In May a fund managed by @HealthCapVC, 1 of the largest specialized providers of venture capital within life scienc… https://t.co/IclRP4YfsL

Europe

US

Lena Wange

IR & Corporate Communications Director

Switchboard: +46 (0)18 780 88 00

Direct phone: +48 73 064 16 36

Send email: ir@orexo.com

Location: Uppsala, Sweden

Dennis Urbaniak

EVP Digital Therapeutics

Switchboard: +1 (0)855 982 7658

Direct phone: +1 973 294 3183

Send email: us.media@orexo.com

Location: New Jersey, US